1. Home
  2. LIVN vs ENVX Comparison

LIVN vs ENVX Comparison

Compare LIVN & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVN
  • ENVX
  • Stock Information
  • Founded
  • LIVN 1987
  • ENVX 2006
  • Country
  • LIVN United Kingdom
  • ENVX United States
  • Employees
  • LIVN N/A
  • ENVX N/A
  • Industry
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ENVX Industrial Machinery/Components
  • Sector
  • LIVN Health Care
  • ENVX Miscellaneous
  • Exchange
  • LIVN Nasdaq
  • ENVX Nasdaq
  • Market Cap
  • LIVN 2.1B
  • ENVX 2.0B
  • IPO Year
  • LIVN 1993
  • ENVX N/A
  • Fundamental
  • Price
  • LIVN $54.53
  • ENVX $9.31
  • Analyst Decision
  • LIVN Strong Buy
  • ENVX Strong Buy
  • Analyst Count
  • LIVN 7
  • ENVX 9
  • Target Price
  • LIVN $59.71
  • ENVX $18.11
  • AVG Volume (30 Days)
  • LIVN 583.7K
  • ENVX 8.4M
  • Earning Date
  • LIVN 10-29-2025
  • ENVX 10-28-2025
  • Dividend Yield
  • LIVN N/A
  • ENVX N/A
  • EPS Growth
  • LIVN N/A
  • ENVX N/A
  • EPS
  • LIVN N/A
  • ENVX N/A
  • Revenue
  • LIVN $1,309,329,000.00
  • ENVX $26,600,000.00
  • Revenue This Year
  • LIVN $11.29
  • ENVX $44.20
  • Revenue Next Year
  • LIVN $6.59
  • ENVX $211.99
  • P/E Ratio
  • LIVN N/A
  • ENVX N/A
  • Revenue Growth
  • LIVN 8.23
  • ENVX 60.04
  • 52 Week Low
  • LIVN $32.48
  • ENVX $4.61
  • 52 Week High
  • LIVN $58.91
  • ENVX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • LIVN 50.60
  • ENVX 44.94
  • Support Level
  • LIVN $56.42
  • ENVX $7.70
  • Resistance Level
  • LIVN $57.53
  • ENVX $9.50
  • Average True Range (ATR)
  • LIVN 1.35
  • ENVX 0.50
  • MACD
  • LIVN -0.70
  • ENVX 0.06
  • Stochastic Oscillator
  • LIVN 10.25
  • ENVX 57.71

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

Share on Social Networks: